Across TCGA pan-cancer cohorts, TRAJ55 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated TRAJ55 data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher TRAJ55 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TRAJ55 expression acts as an unfavorable survival marker, although some lineages such as SKCM and THYM show a favorable association.
THCA, KIRC, and CHOL are the cancer types where TRAJ55 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.